Where is Sabaa located?

Sabaa is headquartered in Cairo, Egypt.

How many employees does Sabaa have?

As of May 31, 2026, the latest employee count at Sabaa is 36.

Is Sabaa a funded company?

Sabaa is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Sabaa rank among its competitors?

Sabaa ranks 381st amongst 1075 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ipsen, which secured $618K in Dec, 2023.

Who are the top competitors of Sabaa?

Sabaa's top competitors include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Among them, Ipsen secured the most recent funding round in December, 2023.

Sabaa - 2026 Company Profile & Competitors

Sabaa's employee count trend

Sabaa has 36 employees as of May 26. Here is Sabaa's employee count trend over the years:

Uncover Sabaa's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sabaa include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Here is the list of Top 10 competitors of Sabaa, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
2nd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	Ampersand Capital, US Bank & 4 others	64/100
3rd	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	ACE & Company, North Sky Capital & 2 others	63/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	62/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Blackstone & 7 others	60/100
8th	Curatio healthcare 2005, Chennai (India), Acquired	Provider of market research services for biopharma sector, and dermatology products for cosmetologists	$44.8M	Camel Investment Limited, ChrysCapital & 13 others	59/100
9th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
10th	Avania 1988, Brunswick (Australia), Acquired	Provider of regulatory, clinical trials and analytic services	-	Kester Capital, Crescent Capital Group & 1 others	55/100
381st	Sabaa 2000, Cairo (Egypt), Unfunded	Pharmaceutical company that focuses on manufacturing generic medicine and clinical trial services	-	-	22/100